Anti-SLAMF5 antibody(DMC286), IgG1 Chimeric mAb

Anti-SLAMF5 antibody(DMC286), IgG1 Chimeric mAb
Artikelnummer Größe Datenblatt Manual SDB Lieferzeit Menge Preis
DIM-DMC100286.10 10 µg - -

7 - 16 Werktage*

145,00 €
DIM-DMC100286.100 100 µg - -

7 - 16 Werktage*

652,00 €
DIM-DMC100286.500 500 µg - -

7 - 16 Werktage*

1.960,00 €
 
Protein function: Self-ligand receptor of the signaling lymphocytic activation molecule (SLAM)... mehr
Produktinformationen "Anti-SLAMF5 antibody(DMC286), IgG1 Chimeric mAb"
Protein function: Self-ligand receptor of the signaling lymphocytic activation molecule (SLAM) family. SLAM receptors triggered by homo- or heterotypic cell-cell interactions are modulating the activation and differentiation of a wide variety of immune cells and thus are involved in the regulation and interconnection of both innate and adaptive immune response. Activities are controlled by presence or absence of small cytoplasmic adapter proteins, SH2D1A/SAP and/or SH2D1B/EAT-2. Can mediate natural killer (NK) cell cytotoxicity dependent on SH2D1A and SH2D1B. Increases proliferative responses of activated T-cells and SH2D1A/SAP does not seem be required for this process. Homophilic interactions enhance interferon gamma/IFNG secretion in lymphocytes and induce platelet stimulation via a SH2D1A-dependent pathway. May serve as a marker for hematopoietic progenitor cells (PubMed:11564780, PubMed:12115647. PubMed:12928397, PubMed:12962726, PubMed:16037392) Required for a prolonged T-cell:B-cell contact, optimal T follicular helper function, and germinal center formation. In germinal centers involved in maintaining B-cell tolerance and in preventing autoimmunity. In mast cells negatively regulates high affinity immunoglobulin epsilon receptor signaling, independent of SH2D1A and SH2D1B but implicating FES and PTPN6/SHP-1 (PubMed:22068234). In macrophages enhances LPS-induced MAPK phosphorylation and NF-kappaB activation and modulates LPS-induced cytokine secretion, involving ITSM 2. Positively regulates macroautophagy in primary dendritic cells via stabilization of IRF8, inhibits TRIM21-mediated proteasomal degradation of IRF8 (PubMed:29434592). [The UniProt Consortium]
Schlagworte: Anti-CD84, Anti-SLAMF5, Anti-LY9B, Anti-SLAMF5, Anti-SLAMF5 antibody(DMC286), IgG1 Chimeric mAb
Hersteller: DIMA
Hersteller-Nr: DMC100286

Eigenschaften

Antikörper-Typ: Monoclonal
Klon: DMC286
Konjugat: No
Wirt: Rabbit
Spezies-Reaktivität: human
Format: Lyophilized

Handhabung & Sicherheit

Lagerung: -20°C (avoid repeat freezing and thawing cycles)
Versand: +20°C (International: +20°C)
Achtung
Nur für Forschungszwecke und Laboruntersuchungen: Nicht für die Anwendung im oder am Menschen!
Hier folgen Informationen zur Produktreferenz. mehr
Hier kriegen Sie ein Zertifikat
oder , um Analysenzertifikate anzufordern.
Bewertungen lesen, schreiben und diskutieren... mehr
Kundenbewertungen für "Anti-SLAMF5 antibody(DMC286), IgG1 Chimeric mAb"
Bewertung schreiben
oder , um eine Produktbewertung abzugeben.
Zuletzt angesehen